Pages that link to "Q35228762"

The following pages link to Edward E. Smissman-Bristol-Myers Squibb Award Address. The role of concepts in structure-activity relationship studies of opioid ligands (Q35228762):

Displaying 27 items.

• Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics (Q24647687) (← links)
• Heteroreceptor Complexes and their Allosteric Receptor-Receptor Interactions as a Novel Biological Principle for Integration of Communication in the CNS: Targets for Drug Development (Q28082673) (← links)
• Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay (Q31546288) (← links)
• Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor. (Q33693780) (← links)
• Concurrent modulation of anxiety and memory (Q33897981) (← links)
• Peptides as receptor ligand drugs and their relationship to G-coupled signal transduction (Q34481473) (← links)
• Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. (Q36437547) (← links)
• δ‐Selective Opioid Peptides Containing a Single Aromatic Residue in the Message Domain: An NMR Conformational Analysis (Q36872039) (← links)
• Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions (Q37349512) (← links)
• Ligand Macromolecule Interactions: Theoretical Principles of Molecular Recognition (Q37778775) (← links)
• Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer (Q38909015) (← links)
• Molecular organization of receptors. Efficacy, agonists, and antagonists (Q40444562) (← links)
• Synthesis and biological evaluation of some novel 1-substituted fentanyl analogs in Swiss albino mice (Q40546885) (← links)
• Structure-activity relationship studies of dynorphin A and related peptides (Q43070634) (← links)
• [6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity (Q43256896) (← links)
• Probing the shape of a hydrophobic pocket in the active site of delta-opioid antagonists. (Q43701358) (← links)
• Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study (Q44343648) (← links)
• Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors (Q44352483) (← links)
• New opioid affinity labels containing maleoyl moiety (Q44353172) (← links)
• Development of highly potent and selective dynorphin A analogues as new medicines (Q46747341) (← links)
• Conformational sampling of bioactive conformers: a low-temperature NMR study of 15N-Leu-enkephalin (Q47783481) (← links)
• Sample and probe: a novel approach for identifying development-specific cis-elements of the enkephalin gene (Q48550920) (← links)
• Stereoselective morphine-like discriminative properties of a new alkylaminonaphthalenic derivative. (Q52167936) (← links)
• Structure-Activity Relationship Studies of 6α- and 6β-Indolylacetamidonaltrexamine Derivatives as Bitopic Mu Opioid Receptor Modulators and Elaboration of the "Message-Address Concept" To Comprehend Their Functional Conversion (Q57159474) (← links)
• Neurologically active plant compounds and peptide hormones: a chirality connection (Q57950540) (← links)
• Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities (Q59215336) (← links)
• Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes (Q77744642) (← links)